Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2

Status

Unknown 6Recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Head & Neck 6

Conditions

Carcinoma, Non-Small-Cell Lung 16Nasopharyngeal Carcinoma 6Colorectal Neoplasms 4Lung Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Neoplasms 2Nasopharyngeal Neoplasms 2Head and Neck Neoplasms 2Squamous Non-small Cell Lung Cancer 1Sarcoma 1Recurrence 1Neuroblastoma 1Meningeal Carcinomatosis 1Melanoma 1Lymphoma, T-Cell 1Locally Advanced Squamous Non-small Cell Lung Cancer 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Breast Cancer Organoids 1Advanced Pancreatic Cancer 1Adenoviridae Infections 1Adenocarcinoma of Lung 1

Interventions

Cisplatin 51Gemcitabine 24Radiotherapy, Intensity-Modulated 21Docetaxel 20Fluorouracil 15camrelizumab 12Drug Therapy 11Radiotherapy 10toripalimab 8Chemoradiotherapy 8Capecitabine 8apatinib 7Induction Chemotherapy 7nimotuzumab 6endostar protein 6Endostatins 6sintilimab 5nedaplatin 5Bevacizumab 5fludarabine 4Cyclophosphamide 4spartalizumab 3fludarabine phosphate 3cisplatin-guanosine adduct 3SSRP1 protein, human 3Paclitaxel 3Injections 3Endoscopy 3tislelizumab 2Vitamin B 12 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Nasopharyngeal Carcinoma × Endostatins × Clear all
NCT02636231 2021-02-03

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 2 Unknown
96 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT03932266 2019-04-30

Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma

Jiangsu Cancer Institute & Hospital

Phase 2 Unknown
73 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT02590133 2017-12-22

A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

Sun Yat-sen University

Phase 2 Unknown
328 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT02907710 2016-09-20

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

First Affiliated Hospital of Guangxi Medical University

Phase 3 Unknown
300 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT01915134 2015-01-01

Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Zhejiang Cancer Hospital

Phase 3 Unknown
362 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT01612286 2014-02-19

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma

Zhejiang Cancer Hospital

Phase 2 Unknown
30 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡